Rice Hall James & Associates LLC Sells 215 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Rice Hall James & Associates LLC trimmed its position in Addus HomeCare Co. (NASDAQ:ADUS) by 0.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,877 shares of the company’s stock after selling 215 shares during the quarter. Rice Hall James & Associates LLC owned 0.18% of Addus HomeCare worth $4,121,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of ADUS. Wasatch Advisors LP raised its holdings in Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after purchasing an additional 110,010 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after buying an additional 75,409 shares in the last quarter. Harbor Capital Advisors Inc. lifted its position in Addus HomeCare by 127.7% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 64,311 shares of the company’s stock valued at $8,555,000 after acquiring an additional 36,071 shares in the last quarter. Barclays PLC boosted its position in shares of Addus HomeCare by 204.8% during the third quarter. Barclays PLC now owns 43,470 shares of the company’s stock valued at $5,783,000 after buying an additional 29,207 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Addus HomeCare by 7.1% during the 3rd quarter. Geode Capital Management LLC now owns 423,934 shares of the company’s stock valued at $56,406,000 after acquiring an additional 28,284 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 39,750 shares of company stock valued at $4,930,750 in the last quarter. 4.60% of the stock is owned by insiders.

Analyst Ratings Changes

ADUS has been the topic of a number of research reports. Stephens raised their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Oppenheimer upped their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Finally, Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $134.22.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $113.22 on Tuesday. Addus HomeCare Co. has a 1 year low of $85.94 and a 1 year high of $136.72. The firm has a market capitalization of $2.05 billion, a PE ratio of 25.91, a price-to-earnings-growth ratio of 1.55 and a beta of 1.00. The business has a 50 day simple moving average of $125.89 and a two-hundred day simple moving average of $127.06.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.